Zai Lab Ltd. (ZLAB)

25.31 -0.27 (-1.06%) USD  |  NASDAQ  |  Oct 07, 16:00
24.80 -0.51 (-2.02%) After-Hours: 20:00
More

Zai Lab EPS Diluted (Quarterly) : -0.4558 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.4558
March 31, 2026 -0.4621
December 31, 2025 -0.4578
September 30, 2025 -0.3267
June 30, 2025 -0.3743
March 31, 2025 -0.4482
December 31, 2024 -0.7999
September 30, 2024 -0.4245
June 30, 2024 -0.8226
March 31, 2024 -0.5495
December 31, 2023 -0.9841
September 30, 2023 -0.7138
Date Value
June 30, 2023 -1.253
March 31, 2023 -0.5111
December 31, 2022 -0.6433
September 30, 2022 -1.681
June 30, 2022 -1.440
March 31, 2022 -0.8623
December 31, 2021 -2.22
September 30, 2021 -1.014
June 30, 2021 -1.755
March 31, 2021 -2.636
December 31, 2019 -0.5287
September 30, 2019 -0.7444

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Kintor Pharmaceutical Ltd. --
Jacobio Pharmaceuticals Group Co., Ltd. --
Adlai Nortye Group Ltd. --
Arrowhead Pharmaceuticals, Inc. -1.355
Oncolytics Biotech, Inc. -0.0788

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -50.91M
Revenue (Quarterly) 106.49M
Total Expenses (Quarterly) 157.40M
Enterprise Value 2.408B
Gross Profit Margin (Quarterly) 54.70%
Profit Margin (Quarterly) -47.81%
Earnings Yield -6.73%
Normalized Earnings Yield -6.726